| Article
During its annual delegates’ meeting, members of the American Medical Society (AMA) adopted new policies in several areas, including expanding access to overdose-reversing medications.
Their action is rooted in their recognition of the opioid epidemic as one of the contributing factors to the...
| Article
The Harvard Drug Group issued a recall of a single lot of Dronabinol Capsules USP, 2.5 mg and Ziprasidone Hydrochloride Capsules, 20 mg, due to a report that some unit dose cartons labeled as Ziprasidone Hydrochloride Capsules, contained blister packages labeled as and containing Dronabinol Capsules...
| Article
In an article in the Cell journal, scientists from China and the University of North Carolina School of Medicine have researched the structural framework of opioid receptors in an effort to build better pain management and limit side effects. “This collaboration revealed conserved, or shared...
| Article
A survey of over 1700 adults (aged ≥18), from a representative sample from 36 states and DC, asked about cannabis use for relief of chronic pain. The results, in JAMA Network Open, found the following:
- 31.0% used cannabis for pain management
- 94.7% also utilized ≥1 pharmacologic pain treatment ...
| Article
What are the major causes of sciatica? What treatments—such as NSAIDs, acetaminophen, systemic corticosteroids, epidurals, exercise therapy, surgery—work best for sciatica? What about prevention? Researchers, publishing their findings in Cureus, reviewed articles to uncover the most effective aids...
| Article
The 2016 Centers for Disease Control and Prevention Guideline for Prescribing Opioids for Chronic Pain was controversial; did it change minds? Apparently it did get practitioners to think “nonopioids” more often. An article published in JAMA Network Open presented information based on cohort study...
| Article
If you’re a patient in pain, and your doctor is sleep deprived, you may be underprescribed analgesics. According to researchers publishing their findings in PNAS (Proceedings of the National Academy of Sciences), practitioner empathy is more than a small part of prescribing. Studying systematic bias...
| Article
The journal of Anesthesiology published a report on the viability of pain management medication development. Using a database and over 1600 data points, researchers analyzed variables to note the probability of “success, duration, and survivorship of pain medication development programs between...
| Article
A new experimental drug, mavacameten, may avert heart surgery or other therapies to lessen the thickness of the septum. Findings from a clinical trial were presented at the 71st annual American College of Cardiology scientific session. Hypertrophic cardiomyopathy causes heart muscle thickening...
| Article
In a narrative review published in Cureus, researchers examined acute pain, which is normal postsurgery, and its potential transition to chronic pain. Postsurgery rates of persistent/subacute pain (lasting over a month) range from 10% to 50%; chronic pain (lasting more than 3 months) is seen in 2%...